Levi & Korsinsky has started an investigation into STAAR Surgical Company over potential breaches of fiduciary duties. This probe could impact current shareholders as it questions the company's management practices. Shareholders can seek more information or legal advice from the firm at no cost. The investigation highlights concerns about corporate governance at STAAR Surgical and may lead to legal action or shareholder claims.
The investigation into STAAR Surgical Company by Levi & Korsinsky, LLP is noted alongside Pluang's health sector market data as of Sep 24, 2026 04:41 WIB. For readers following health stocks, here is Pluang's market snapshot: out of 100 priced US health-sector stocks, 22 rose and 78 fell today. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 14.86 with a -5.89% change and a typical hold time of 10 days, Quest Diagnostics Inc (DGX) at USD 232.90 with a -5.51% change and a typical hold time of 55 days, and Crispr Therapeutics AG (CRSP) at USD 55.80 with a -5.47% change and a typical hold time of 77 days, with Pluang order activity heavily skewed to selling for CRSP at 100% sell and 0% buy.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
Lindian Resources has stockpiled 125,000 tonnes of ore at its Kangankunde Rare Earths Project in Malawi, ahead of schedule for commissioning and first monazite concentrate production by the end of 2026. Mining operations are well established with the...
